Allergy and Asthma Proceedings

Papers
(The TQCC of Allergy and Asthma Proceedings is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Impact of steroids on the immune profiles of children with asthma living in the inner-city80
Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist45
Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination36
The role of leukocyte activation in suspected Non-IgE excipient-related COVID-19 vaccine reactions: An exploratory hypothesis-driven study of pathogenesis29
SARS-CoV-2 infection and the human immune system: A continuing journey of discovery29
Operationalizing shared decision making in clinical practice25
Molecular allergy diagnostics in predicting oral cow's milk challenge outcome in Finnish children25
Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks24
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study21
Future directions in allergen immunotherapy21
Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being21
Association of exposure to ambient particulate matter with asthma in children: Systematic review and meta-analysis20
Venom allergen immunotherapy19
Demographics and characteristics of leadership at allergy and immunology fellowships in the U.S. as of 202218
TEV/FEV3 as a coherent metric of small airway dysfunction in childhood asthma18
Abstracts presented at the Western Society of Allergy, Asthma & Immunology, Annual Scientific Session, February 6-10, 2022, Maui, Hawaii16
For the Patient15
For the Patient15
For the Patient14
Body weight trajectory of non-obese asthmatics: Relationship with inhaled corticosteroids maintenance therapy14
Evaluation and management of chronic cough in adults14
Quality of life in primary immunodeficiency: Its contribution to shared decision-making and patient outcomes14
The burden of systemic corticosteroids in patients with chronic rhinosinusitis with nasal polyps13
Assessment of pediatric patients with suspected nonsteroidal anti-inflammatory drug hypersensitivity13
Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course12
Comparison of commercial allergen extract with various milk products of skin prick tests in diagnosing cow's milk protein allergy12
Epinephrine autoinjector prescribing following anaphylaxis presentation to the emergency department12
Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-1912
The safety of initial single therapeutic dose challenge with a 5-day prolonged drug provocation test in children with a history of low-risk non-immediate reactions to beta-lactam antibiotics11
Unraveling allergic, pseudoallergic, and idiosyncratic complexities of hypersensitivity reactions to NSAIDs11
Is it time for the A/I (allergist/immunologist) to embrace AI (artificial intelligence) in diagnosis and treatment of the inborn errors of immunity?11
Diagnostic utility of basophil CD203c expression in β-lactam allergy11
Systematic review of omalizumab for refractory clonal and non-clonal mast cell activation syndrome11
For the Patient11
Treatment strategies for postviral olfactory dysfunction: A systematic review11
Artificial intelligence and allergy: Shaping the future of diagnosis and therapy11
Association between air pollution and the prevalence of allergic rhinitis in Chinese children: A systematic review and meta-analysis11
For the Patient11
Can depression and anxiety be predicted in hereditary angioedema? A comprehensive assessment11
Effects of mechanical washing and drying on the removal of pet allergens11
A tribute to allergy and immunology fellowship training program directors and to the fellows they train10
Diagnostic value of YKL-40 for patients with asthma: A meta-analysis10
From burden to breakthrough: Advances in hereditary angioedema, drug allergy, and allergic disease prevention10
Navigating the management complexity in long-term asymptomatic immunodeficiency10
Abstracts Presented at the Western Society of Allergy, Asthma & Immunology, February 4‐8, 2024, Koloa, Hawaii10
Guidelines for management of hereditary angioedema: What is new? What is missing?10
Oral food challenge to milk is still necessary to diagnose cow's milk allergy and should be conducted in adequate facilities10
For the patient10
Eosinophilic granulomatosis with polyangiitis in allergic asthma: Efforts to make early diagnosis possible10
A case of a rash after tetanus-diphtheria-pertussis and meningococcal vaccination9
Benralizumab in the management of rare primary eosinophilic lung diseases9
Evaluation of atopic diseases in patients with allergic contact dermatitis9
Real-world effectiveness of dupilumab versus benralizumab and mepolizumab9
Metal implant allergy: A retrospective cohort analysis at a university allergy practice9
Primary Immunodeficiency: Specific antibody deficiency with normal IgG9
Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy9
Presented at the Western Society of Allergy, Asthma & Immunology, February 5‐9, 2023, Kamuela, Hawaii9
The long COVID syndrome: A conundrum for the allergist/immunologist9
Hematopoietic stem cell transplantation for primary immunodeficiency8
Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study8
Treatment options for chronic rhinosinusitis with nasal polyps8
Safety of ciclesonide in children with asthma: A review of randomized controlled trials8
The association of timothy grass allergy and cat ownership on cat sensitization8
Prophylactic therapy with subcutaneous C1-inhibitor is associated with sustained symptom control in patients with hereditary angioedema8
Cost-effectiveness of school integrated pest management and air filtration in students with asthma8
Paucigranulocytic asthma: Do sputum macrophages matter?8
Early clinical improvement of anosmia and sinus nitric oxide in chronic rhinosinusitis with nasal polyps subjects treated with dupilumab8
Overview of secondary immunodeficiency8
Shared decision-making in the management of hereditary angioedema: An analysis of patient and physician perspectives8
Clinical features of anaphylaxis in children8
Penicillin allergy labels are associated with a greater number of courses of antibiotics after hospitalization7
Abstracts published from the New England Society of Allergy Annual Fall Meeting, October 22‐23, 2022, Portsmouth, NH7
Impact of penicillin allergy labels among pneumonia admissions at an academic children's center7
Efficacy of anti-interleukin 5 therapy in hypereosinophilic syndrome: An updated systematic review and meta-analysis7
Birch-naive, oak-allergic subjects' response to birch pollen in an environmental chamber7
For the Patient7
Curcumin does not significantly affect immediate skin tests7
Assessing cross-reactivity in allergen immunotherapy7
Adding tiotropium or long-acting β2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization7
Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-27
Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy7
Markers of eosinophilic airway inflammation in patients with asthma and allergic rhinitis7
Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study7
COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications6
Peanut allergy in an adult following cardiac transplant from a non-atopic donor6
The long-term outcomes of mepolizumab treatment at 100 mg dose on idiopathic chronic eosinophilic pneumonia: A real-life experience6
Delayed pressure urticaria successfully treated with omalizumab: A tertiary-level health-care center experience6
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan6
Immunodeficiency: Burden of Illness6
Clinical and economic burden of chronic rhinosinusitis with nasal polyposis: A U.S. administrative claims analysis6
Evaluation of allergic diseases in children diagnosed with cutaneous mastocytosis6
Quality of life and burden of disease in patients with hereditary angioedema and their caregivers6
2-Octyl cyanoacrylate, a hidden allergen, a common cause of postsurgical allergic contact dermatitis6
Efficacy of parenteral bronchodilators on ventilatory outcomes in pediatric critical asthma: a national cohort study6
Diagnosis of eosinophilic esophagitis in patients with dysphagia during the Coronavirus Disease 2019 (COVID-19) pandemic6
Delayed systemic urticarial reactions following mRNA COVID-19 vaccination6
Abstracts presented at the Eastern Allergy Conference, June 3‐6, 2021, Palm Beach, Florida6
Real-world effectiveness and predictors of super-responders to dupilumab in a Chinese uncontrolled asthma cohort6
Essentials of an immunodeficiency primer: A practical reference for the allergist/immunologist and the allergy-immunology fellow-in-training (FIT)6
A masquerade of recurrent anaphylaxis6
Multicenter questionnaire study investigating characteristics of adults with unexplained chronic cough versus explained chronic cough6
0.13393902778625